Mumbai: In a boost to the fight against Covid-19, global healthcare company Abbott launched a Covid-19 home test kit for the Indian market. Priced at Rs 325, the home test care kit is meant to detect the virus among children and adults affected or showing symptoms of Covid-19.
To meet the demand of Covid-19 testing, Abbot said in a statement that it is set to deliver millions of Panbio COVID-19 rapid antigen tests that can be administered for self-use without burdening the already stressed healthcare system in both urban and rural India.
In alignment with the current ICMR advisory on self-use, these tests will be made available to ramp up testing of symptomatic and asymptomatic individuals and contacts of confirmed coronavirus cases, it added.
“Scaling access to easy, accurate, and fast testing can speed up the country’s preparedness and curb community contagion,” ICMR former Director-General Nirmal Kumar Ganguly said. Self-testing at home empowers individuals with the ability to carry out the first line of protection against disease transmission, he added.
India has reported 31,443 new cases in last 24 hours; lowest in 118 days and also 38.14 Cr. Vaccine Doses administered so far under Nationwide Vaccination Drive.
